Skeletal pain in postmenopausal women with osteoporosis: prevalence and course during raloxifene treatment in a prospective observational study of 6 months duration

References

• Silverman SL, Piziak VK, Chen P, et al. Relationship of health related quality of life to prevalent and new or worsening back pain in postmenopausal women with osteoporosis. J Rheumatol 2005;32:2405–9
   PubMed Web of Science ®Google Scholar
• Nevitt MC, Ettinger B, Black DM, et al. The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med 1998;128:793–800
   PubMed Web of Science ®Google Scholar
• Huang C, Ross PD, Wasnich RD. Vertebral fractures and other predictors of back pain among older women. J Bone Miner Res 1996;11:1026–32
   Google Scholar
• Ettinger B, Black DM, Nevitt MC, et al. Contributions of vertebral deformities to chronic back pain and disability [The Study of Osteoporotic Fractures Research Group]. J Bone Miner Res 1992;7:449–56
   PubMed Web of Science ®Google Scholar
• Ismail AA, Cooper C, Felsenberg D, et al. Number and type of vertebral deformities: epidemiological characteristics and relation to back pain and height loss. Osteoporosis Int 1999;9:206–13
   PubMed Web of Science ®Google Scholar
• Kamimura M, Uchiyama S, Takahara K, et al. Urinary excretion of type I collagen cross-linked N-telopeptide and serum bone-specific alkaline phosphatase analysis to determine the correlation of age and back-pain related changes in elderly women. J Bone Miner Metab 2005;23:495–500
   PubMed Web of Science ®Google Scholar
• Silverman SL, Azria M. The analgesic role of calcitonin following osteoporotic fracture. Osteoporosis Int 2002;13:858–67
   PubMed Web of Science ®Google Scholar
• Watts NB. Is percutaneous vertebral augmentation (vertebroplasty) effective treatment for painful vertebral fractures? Am J Med 2003;114:326–8
   PubMed Web of Science ®Google Scholar
• Treede RD. The physiology of bone pain. Osteologie 1999;4:195–200
   Google Scholar
• Jarvik JG, Deyo RA. Diagnostic evaluation of low back pain with emphasis on imaging. Ann Intern Med 2002;137:586–97
   PubMed Web of Science ®Google Scholar
• Knopp JA, Diner BM, Blitz M, et al. Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: a systematic review of randomized, controlled trials. Osteoporosis Int 2005;16:1281–90
   PubMed Web of Science ®Google Scholar
• Lyritis GP, Paspati I, Karachalios T, et al. Pain relief from nasal salmon calcitonin in osteoporotic vertebral crush fractures. A double blind, placebo-controlled clinical study. Acta Orthop Scand Suppl 1997;275:112–4
   PubMedGoogle Scholar
• Gennari C. Analgesic effect of calcitonin in osteoporosis. Bone 2002;30\(Suppl 5):67S–70S
   Google Scholar
• Papadokostakis G, Damilakis J, Mantzouranis E, et al. The effectiveness of calcitonin on chronic back pain and daily activities in postmenopausal women with osteoporosis. Eur Spine J 2006;15:356–62
   PubMed Web of Science ®Google Scholar
• Nevitt MC, Thompson DE, Black DM, et al. Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Arch Intern Med 2000;160:77–85
   PubMed Web of Science ®Google Scholar
• Genant HK, Halse J, Briney WG, et al. The effects of teriparatide on the incidence of back pain in postmenopausal women with osteoporosis. Curr Med Res Opin 2005;21:1027–34
   PubMed Web of Science ®Google Scholar
• Miller PD, Shergy WJ, Body JJ, et al. Longterm reduction of back pain risk in women with osteoporosis treated with teriparatide compared with alendronate. J Rheumatol 2005;32:1556–62
   PubMed Web of Science ®Google Scholar
• Nevitt MC, Chen P, Dore RK, et al. Reduced risk of back pain following teriparatide treatment: a meta-analysis. Osteoporosis Int 2006;17:273–80
   PubMed Web of Science ®Google Scholar
• Musgrave DS, Vogt MT, Nevitt MC, Cauley JA. Back problems among postmenopausal women taking estrogen replacement therapy: the study of osteoporotic fractures. Spine 2001;26: 1606–12
   PubMed Web of Science ®Google Scholar
• Siris E, Adachi JD, Lu Y, et al. Effect of raloxifene on fracture severity in postmenopausal women with osteoporosis: results from the MORE study. Osteoporosis Int 2002;13:907–13
   PubMed Web of Science ®Google Scholar
• Ringe JD, Mühlenbacher D, Beck H. Diagnosis and therapy of osteoporosis in medical practice in Germany – a survey of 5902 female patients with osteoporosis prior to and after raloxifene treatment. Osteologie 2003;12:23–30
   Google Scholar
• Liu-Ambrose T, Eng JJ, Khan KM, et al. The influence of back pain on balance and functional mobility in 65- to 75-year-old women with osteoporosis. Osteoporosis Int 2002;13: 868–73
   Google Scholar
• Ringe JD, Miethe D, Pittrow D, Wegscheider K. Analgesic efficacy of flupirtine in primary care of patients with osteoporosis related pain. A multivariate analysis. Arzneimittelforschung 2003;53:496–502
   PubMed Web of Science ®Google Scholar
• Papadokostakis G, Katonis P, Damilakis J, Hadjipavlou A. Does raloxifene treatment influence back pain and disability among postmenopausal women with osteoporosis? Eur Spine J 2005;14:977–81
   PubMed Web of Science ®Google Scholar
• Hansdottir H, Franzson L, Prestwood K, Sigurdsson G. The effect of raloxifene on markers of bone turnover in older women living in long-term care facilities. Am Geriatr Soc 2004;52:779–83
   PubMed Web of Science ®Google Scholar
• Stepan J, Michalska D, Zikan V, Vokrouhlicka J. Biochemical markers of type I collagen synthesis and degradation in monitoring osteoporosis treatment with raloxifene or alendronate. J Bone Miner Res 2002;17(Suppl 1):S233
   Google Scholar
• Neven P, Quail D, Marin F, et al. Comparing raloxifene with continuous combined estrogen–progestin therapy in postmenopausal women: review of Euralox 1. Maturitas 2005;52:87–101
   PubMed Web of Science ®Google Scholar
• Payne R. Mechanisms and management of bone pain. Cancer 1997;80(Suppl 8):1608–13
   PubMed Web of Science ®Google Scholar
• Haegerstam GAT. Pathophysiology of bone pain. Acta Orthop Scand 2001;72:308–17
   PubMedGoogle Scholar
• Qu Y, Wong M, Thiebaud D, Stock JL. The effect of raloxifene therapy on the risk of new clinical vertebral fractures at three and six months: a secondary analysis of the MORE trial. Curr Med Res Opin 2005;21:1955–9
   PubMed Web of Science ®Google Scholar
• Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. Results from a 3-year randomised clinical trial. J Am Med Assoc 1999;282:637–45
   PubMed Web of Science ®Google Scholar
• Scharla S, Oertel H, Helsberg K, et al. J Bone Miner Res 2005;20\(Suppl 1):M318
   Google Scholar
• Scharla S, Oertel H, Helsberg K, et al. J Bone Miner Res 2005;20\(Suppl 1):M398
   Google Scholar
• Scharla S, Oertel H, Helsberg K, et al. Ann Rheum Dis 2005;64\(Suppl 3):1144
   Google Scholar